Aquatic Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Sell |
7,362
-91,972
| -93% | -$4.47M | 0.01% | 902 |
|
|
2025
Q1 | $3.38M | Buy |
99,334
+51,690
| +108% | +$1.76M | 0.09% | 289 |
|
|
2024
Q4 | $1.88M | Sell |
47,644
-4,656
| -9% | -$183K | 0.05% | 390 |
|
|
2024
Q3 | $2.46M | Buy |
52,300
+38,300
| +274% | +$1.8M | 0.06% | 318 |
|
|
2024
Q2 | $756K | Sell |
14,000
-7,000
| -33% | -$378K | 0.03% | 454 |
|
|
2024
Q1 | $1.43M | Sell |
21,000
-17,100
| -45% | -$1.17M | 0.05% | 316 |
|
|
2023
Q4 | $2.39M | Buy |
38,100
+29,200
| +328% | +$1.83M | 0.06% | 292 |
|
|
2023
Q3 | $404K | Buy |
8,900
+5,700
| +178% | +$259K | 0.02% | 532 |
|
|
2023
Q2 | $180K | Sell |
3,200
-15,900
| -83% | -$894K | 0.01% | 697 |
|
|
2023
Q1 | $864K | Buy |
+19,100
| New | +$864K | 0.05% | 303 |
|